Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer

Chun Liang Lai, Chun Ming Tsai, Chao Hua Chiu, Gwo Shu Wang, Wei Juin Su, Yuh Min Chen, Reury Perng Perng

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science